Drug Trial Radar · NCT06292013
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
Last checked: Nov 20, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
17,300
Planned (sponsor's estimate)
Start
Mar 5, 2024
Primary completion
Mar 2029
Study completion Mar 2029
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Mar 4, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke. The study drug will be administered subcutaneously (SC) (under the skin). Approximately 1700 additional participants will be enrolled in an addendum to explore Lp(a) lowering with an alternative dosing schema.
Conditions
- Atherosclerotic Cardiovascular Disease (ASCVD)
- Elevated Lp(a)
Interventions
Lepodisiran SodiumDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Occurrence of Any Component of the Major Adverse Cardiac Event (MACE)-4 Composite EndpointTime frame: Baseline up to End of Study (About 4.5 Years)
Locations
928 sites in 28 countries. Site status is shown where the registry gives one.
Birmingham Clinical Research
Birmingham, Alabama
Alliance for Multispecialty Research, LLC
Daphne, Alabama
SEC Clinical Research
Dothan, Alabama
Alliance for Multispecialty Research, LLC
Mobile, Alabama
Mobile Heart Specialists
Mobile, Alabama
Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC
Gilbert, Arizona
Mercy Gilbert Medical Center
Gilbert, Arizona
Sun City Clinical Research
Glendale, Arizona
Elite Clinical Studies, LLC
Phoenix, Arizona
Helios Clinical Research - Phoenix
Phoenix, Arizona
Absolute Clinical Research
Phoenix, Arizona
Clinical Research Institute of Arizona (CRI) - Sun City West
Sun City West, Arizona
Pima Heart
Tucson, Arizona
Synexus Clinical Research US, Inc./Orange Grove Family Practice
Tucson, Arizona
Eclipse Clinical Research
Tucson, Arizona
Cardiology and Medicine Clinic
Little Rock, Arkansas
National Heart Institute
Beverly Hills, California
Valley Clinical Trials, Inc.
Covina, California
Neighborhood Healthcare Institute of Health
Escondido, California
HB Clinical Trials - Fountain Valley
Fountain Valley, California
Care Access - Huntington Beach
Huntington Beach, California
310 Clinical Research
Inglewood, California
UCSD - Altman Clinical and Translational Research Institute (ACTRI)
La Jolla, California
Scripps Whittier Diabetes Institute
La Jolla, California
First Valley Medical Group
Lancaster, California
MemorialCare Health System - Long Beach Medical Center
Long Beach, California
Ark Clinical Research
Long Beach, California
Keck School of Medicine of USC
Los Angeles, California
Cardiovascular Research Foundation of Southern California
Los Angeles, California
Valley Clinical Trials, LLC dba Flourish Research
Northridge, California
Desert Oasis Healthcare Medical Group
Palm Springs, California
Artemis Institute for Clinical Research
San Diego, California
Care Access - Santa Clarita
Santa Clarita, California
Stanford University Medical Center
Stanford, California
Olive View-UCLA Medical Center
Sylmar, California
Care Access - Thousand Oaks
Thousand Oaks, California
Med Partners, Inc. dba Premiere Medical Center of Burbank, Inc.
Toluca Lake, California
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California
UCLA South Bay Endocrinology
Torrance, California
InvivoCure
Van Nuys, California
Showing 40 of 928 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.